The global Burn Care Market, valued at US$2.46 billion in 2024, is forecasted to grow at a robust CAGR of 5.6%, reaching US$2.55 billion in 2025 and an impressive US$3.35 billion by 2030. This market ...

The FDA has approved Zevaskyn (prademagene zamikeracel) for the treatment of recessive dystrophic epidermolysis bullosa, a rare genetic skin disorder.

The global Burn Care Market, valued at US$2.46 billion in 2024, is forecasted to grow at a robust CAGR of 5.6%, reaching US$2 ...

And now, it’s also one of the key powerhouse ingredients behind the best-selling Anti-Blemish & Scar Repair Serum by 47 Skin.

Before embarking on your journey, assemble a well-stocked wound care kit. Include items such as sterile gauze, adhesive ...

The cast and crew took over the Grand Hotel Quisisana on Capri in the spring of 2024 to film the movie. To grasp the scope of ...

UK medical products maker Smith+Nephew beat first-quarter revenue growth expectations and maintained its full-year sales and profit margin forecasts on Wednesday, despite the potential impact of U.S.

Though based out of and serving the Essex Town and Junction region primarily, the Players welcome anyone in the region who ...

The condition, recessive dystrophic epidermolysis bullosa, causes chronic wounds and has an 84% mortality rate by age 40.

This award will support research led by Suresh Thallapuranam, in collaboration with Kyle Quinn and Narasimhan Rajaram from the Department of Biomedical Engineering, along with Jingyi Chen from the ...

Writer-director Kip Williams brings a high-tech adaptation of the classic Oscar Wilde story to Broadway. Snook takes on all ...